Status:
UNKNOWN
Heat Therapy and Omega 3 on Cardio-Metabolic Health
Lead Sponsor:
Texas Tech University
Conditions:
Hypertension
Eligibility:
All Genders
18-65 years
Phase:
NA
Brief Summary
Currently, controlled studies are lacking which test the benefits of: 1) ω3 PUFA; and 2) heat therapy on improving vascular-metabolic-microbiota health in Hispanic American populations. The investigat...
Detailed Description
In a double-blind, placebo-controlled design, participants will be randomized to the following experimental treatments: 1. 4 g omega 3 daily for 12 weeks combined with 6 weeks of heat therapy 2. Plac...
Eligibility Criteria
Inclusion
- BMI\>30-40,
- fasting glucose 100-125,
- blood pressure 130-139/80-89,
- Hispanic American,
- age 18-65 years
Exclusion
- non-Hispanic,
- BMI\<30, \>40,
- fasting glucose \<100, \>125,
- blood pressure \<130,\>139 systolic, \>90 diastolic,
- age \<18, \>65 years
Key Trial Info
Start Date :
August 20 2019
Trial Type :
INTERVENTIONAL
Allocation :
ESTIMATED
End Date :
August 1 2020
Estimated Enrollment :
60 Patients enrolled
Trial Details
Trial ID
NCT04051034
Start Date
August 20 2019
End Date
August 1 2020
Last Update
August 14 2019
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Eric Rivas
Lubbock, Texas, United States, 79424